Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  MELK inhibitor OTS167
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: OTS1070103, NCI-2017-00301, NCT02926690
Start Over